Shaan Gandhi

Shaan Gandhi, MD, DPhil, currently serves as the Vice President and Head of Strategic Partnerships at Pfizer Ignite, a program designed to enhance biotech innovation through Pfizer's extensive resources. In addition to this role, Shaan Gandhi holds an independent board member position at 1910 Genetics and has been a board member for several companies, including DICE Therapeutics, Vigil Neuroscience, Kyverna Therapeutics, Transition Bio, Inc., StrideBio, Inc., CAMP4 Therapeutics, Mestag Therapeutics, and Garuda Therapeutics. Academic credentials include an MD from Harvard Medical School, an MBA from Harvard Business School, a DPhil in Medical Oncology from the University of Oxford, and a BS in Biochemistry from Case Western Reserve University.